We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+13.71%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.67B
AUM Growth
+$159M
Cap. Flow
+$11.7M
Cap. Flow %
0.7%
Top 10 Hldgs %
44.6%
Holding
84
New
7
Increased
30
Reduced
18
Closed
5

Top Buys

Rank Stock Value
1
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$24.9M
2
ARNA
Arena Pharmaceuticals Inc
ARNA
+$17.7M
3
ATEC icon
Alphatec Holdings
ATEC
+$15.5M
4
INSM icon
Insmed
INSM
+$12.9M
5
RLAY icon
Relay Therapeutics
RLAY
+$12.9M

Top Sells

Rank Stock Value
1
PRTA icon
Prothena Corp
PRTA
+$31.4M
2
CDNA icon
CareDx
CDNA
+$25.2M
3
BTAI icon
BioXcel Therapeutics
BTAI
+$15.5M
4
MRVI icon
Maravai LifeSciences
MRVI
+$11.2M
5
HCAT icon
Health Catalyst
HCAT
+$11.1M

Sector Composition

Rank Sector Weight
1 Healthcare 83.7%
2 Communication Services 4.44%
3 Energy 0.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATEC icon
26
Alphatec Holdings
ATEC
$1.46B
$27M 1.62%
1,760,811
+1,003,822
+133% +$15.5M
KRMD icon
27
KORU Medical Systems
KRMD
$189M
$25.1M 1.51%
5,424,347
-60,891
-1% -$239K
GMAB icon
28
Genmab
GMAB
$17.7B
$24.8M 1.49%
607,046
-130,215
-18% -$5.02M
STIM icon
29
Neuronetics
STIM
$138M
$23.5M 1.41%
1,463,836
+314,059
+27% +$4.34M
SIBN icon
30
SI-BONE Inc
SIBN
$788M
$22.2M 1.33%
704,230
+2,498
+0.4% +$80.8K
RARE icon
31
Ultragenyx Pharmaceutical
RARE
$2.45B
$21.9M 1.31%
229,246
+11,787
+5% +$1.23M
AXNX
32
DELISTED
Axonics, Inc. Common Stock
AXNX
$21.1M 1.27%
332,873
+51,345
+18% +$3.03M
LITS
33
Lite Strategy Inc
LITS
$32.8M
$19.9M 1.2%
349,785
+30,838
+10% +$1.98M
CDXS icon
34
Codexis
CDXS
$151M
$15.9M 0.96%
703,166
-1,020
-0.1% -$22.1K
KIDS icon
35
OrthoPediatrics
KIDS
$519M
$14.5M 0.87%
229,876
+2,426
+1% +$139K
RLAY icon
36
Relay Therapeutics
RLAY
$4.1B
$14.3M 0.86%
+390,555
New +$12.9M
ITMR
37
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$13.8M 0.83%
586,420
+211,420
+56% +$4.72M
APTO
38
DELISTED
Aptose Biosciences, Inc.
APTO
$13.7M 0.82%
9,145
+2,250
+33% +$4.9M
AKU
39
DELISTED
Akumin Inc
AKU
$11.2M 0.67%
3,559,911
+1,565,711
+79% +$4.71M
XBI icon
40
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$11.2M 0.67%
+82,669
New +$10.9M
TCRR
41
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$10.6M 0.63%
644,216
-182,258
-22% -$3.68M
JYNT icon
42
The Joint Corp
JYNT
$118M
$9.8M 0.59%
116,763
-101,322
-46% -$6.28M
QDEL icon
43
QuidelOrtho
QDEL
$1.14B
$9.28M 0.56%
72,424
-37,746
-34% -$4.44M
NVTA
44
DELISTED
Invitae Corporation
NVTA
$8.61M 0.52%
255,316
+2,874
+1% +$93.5K
MRVI icon
45
Maravai LifeSciences
MRVI
$969M
$8.44M 0.51%
202,138
-288,911
-59% -$11.2M
MIRO
46
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
$5.53M 0.33%
+475,000
New +$6.12M
ANNX icon
47
Annexon
ANNX
$835M
$4.64M 0.28%
+206,077
New +$4.57M
SLP icon
48
Simulations Plus
SLP
$369M
$4.16M 0.25%
75,832
+1,752
+2% +$100K
LHCG
49
DELISTED
LHC Group LLC
LHCG
$3.09M 0.19%
15,422
-78
-0.5% -$15.6K
SIEN
50
DELISTED
Sientra, Inc.
SIEN
$2.59M 0.16%
32,535
+2,535
+8% +$180K
1
2
3 4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, First Light Asset Management held 84 positions worth $1.67B, up 11% from $1.51B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

First Light Asset Management's Q2 2021 filing shows 7 new, 30 increased, 18 reduced and 5 closed positions. Its largest new stake was Relay Therapeutics: 390,555 shares worth $14.3M. The largest sale was Prothena Corp, an estimated $31.4M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 84% a quarter earlier, followed by Communication Services and Energy.

  • First Light Asset Management's largest Q2 2021 buy was Relay Therapeutics: 390,555 shares worth $14.3M.
  • First Light Asset Management added most to Turning Point Therapeutics, Inc. Common Stock in Q2 2021, an estimated $24.9M increase.
  • First Light Asset Management's biggest Q2 2021 reduction was Prothena Corp, cutting an estimated $31.4M.
  • First Light Asset Management fully exited BioXcel Therapeutics in Q2 2021, selling an estimated $15.5M.
  • First Light Asset Management's ten largest holdings make up 45% of its $1.67B portfolio in Q2 2021.
  • First Light Asset Management opened 7 new positions and closed 5 in Q2 2021.
  • First Light Asset Management's portfolio value rose 11% quarter-over-quarter to $1.67B.

Based on First Light Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.